Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG: 1349)

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Statistics

Total Valuation

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. has a market cap or net worth of HKD 7.41 billion. The enterprise value is 6.27 billion.

Market Cap	7.41B
Enterprise Value	6.27B

Important Dates

The last earnings date was Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Aug 26, 2024

Share Statistics

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. has 1.04 billion shares outstanding. The number of shares has increased by 0.54% in one year.

Current Share Class	n/a
Shares Outstanding	1.04B
Shares Change (YoY)	+0.54%
Shares Change (QoQ)	+12.82%
Owned by Insiders (%)	18.21%
Owned by Institutions (%)	3.70%
Float	410.26M

Valuation Ratios

The trailing PE ratio is 24.82.

PE Ratio	24.82
Forward PE	n/a
PS Ratio	3.78
PB Ratio	1.05
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 70.72, with an EV/FCF ratio of -278.08.

EV / Earnings	53.83
EV / Sales	8.19
EV / EBITDA	70.72
EV / EBIT	121.25
EV / FCF	-278.08

Financial Position

The company has a current ratio of 6.23, with a Debt / Equity ratio of 0.00.

Current Ratio	6.23
Quick Ratio	5.89
Debt / Equity	0.00
Debt / EBITDA	0.14
Debt / FCF	-0.55
Interest Coverage	57.80

Financial Efficiency

Return on equity (ROE) is 4.47% and return on invested capital (ROIC) is 1.21%.

Return on Equity (ROE)	4.47%
Return on Assets (ROA)	1.05%
Return on Capital (ROIC)	1.21%
Revenue Per Employee	808,078
Profits Per Employee	122,919
Employee Count	948
Asset Turnover	0.25
Inventory Turnover	1.45

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.32% in the last 52 weeks. The beta is 0.29, so Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.'s price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	+2.32%
50-Day Moving Average	2.57
200-Day Moving Average	2.16
Relative Strength Index (RSI)	46.48
Average Volume (20 Days)	6,394,534

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. had revenue of HKD 766.06 million and earned 116.53 million in profits. Earnings per share was 0.11.

Revenue	766.06M
Gross Profit	694.99M
Operating Income	51.73M
Pretax Income	108.06M
Net Income	116.53M
EBITDA	79.80M
EBIT	51.73M
Earnings Per Share (EPS)	0.11

Balance Sheet

The company has 1.15 billion in cash and 12.51 million in debt, giving a net cash position of 1.14 billion or 1.10 per share.

Cash & Cash Equivalents	1.15B
Total Debt	12.51M
Net Cash	1.14B
Net Cash Per Share	1.10
Equity (Book Value)	2.61B
Book Value Per Share	2.51
Working Capital	1.54B

Cash Flow

In the last 12 months, operating cash flow was 10.14 million and capital expenditures -32.69 million, giving a free cash flow of -22.56 million.

Operating Cash Flow	10.14M
Capital Expenditures	-32.69M
Free Cash Flow	-22.56M
FCF Per Share	-0.02

Margins

Gross margin is 90.72%, with operating and profit margins of 6.75% and 15.21%.

Gross Margin	90.72%
Operating Margin	6.75%
Pretax Margin	14.11%
Profit Margin	15.21%
EBITDA Margin	10.42%
EBIT Margin	6.75%
FCF Margin	-2.94%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 1.59%.

Dividend Per Share	0.04
Dividend Yield	1.59%
Dividend Growth (YoY)	22.06%
Years of Dividend Growth	n/a
Payout Ratio	88.08%
Buyback Yield	-0.54%
Shareholder Yield	1.05%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. has an Altman Z-Score of 15.23.

Altman Z-Score	15.23
Piotroski F-Score	n/a